Literature DB >> 2669495

CA 125 in the epithelium closely related to the embryonic ectoderm: the periderm and the amnion.

Y Nanbu1, S Fujii, I Konishi, H Nonogaki, T Mori.   

Abstract

The amnion is believed to be derived from either cytotrophoblastic cells or embryonic ectoderm. However, it produces and secretes CA 125, which is considered a differentiation antigen of fetal coelomic epithelium derived from the mesoderm of germ cells. To verify this, the immunohistochemical localization of CA 125 in human fetal tissues (between 7 and 23 weeks of gestation) derived from the ectoderm, endoderm, or mesoderm, and in the fetal membranes and placenta was studied. Among the mesoderm-derived tissues, only the fetal coelomic epithelium-related tissues were positive for anti-CA 125 from 15 weeks of gestation. The endoderm-derived tissues did not react with anti-CA 125. However, among the ectoderm-derived tissues, only the periderm reacted with anti-CA 125 from 7 weeks until it sloughed from the stratum intermedium by 23 weeks of gestation. Among the fetal membranes and placenta, only the amnion reacted with anti-CA 125 from 9 weeks to term. These findings indicate that the amnion and the periderm, both of which constitute the epithelia covering the amniotic cavity, in addition to the fetal coelomic epithelium-related tissues, produce CA 125.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2669495     DOI: 10.1016/0002-9378(89)90542-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Differentiation potential of rat amnion.

Authors:  V Knezevic
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

2.  MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.

Authors:  Ying Wang; Dong-Joo Cheon; Zhen Lu; Sheena L Cunningham; Chun-Ming Chen; Robert Z Luo; Deyin Xing; Sandra Orsulic; Robert C Bast; Richard R Behringer
Journal:  Differentiation       Date:  2008-07-02       Impact factor: 3.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.